LGM Pharma Expands U.S. CDMO Capacity and Navigates Reshoring, Supply-Chain Risks

24/7 Biopharma had the opportunity to sit down for a long-form interview about the state of the CDMO industry with Hamilton Lenox, Chief Commercial Officer, and Matt Grazioli, Senior Marketing Manager, of LGM Pharma. The discussion touched on LGM’s recent facility expansions, shifting market demands in the CDMO segment, and how the company is responding to the uncertain state of the global economy, among various other topics.

LATEST VIDEO

Latest news

11th August 2026

Cambrex Milan Celebrates 80th Anniversary with Construction of New $30 Million R&D Facility

10th August 2026

Bristol Myers Squibb Advances U.S. Manufacturing Investment with New $2.3 Billion Campus in Houston, Texas

4th August 2026

FUJIFILM Biotechnologies Transitions Leadership to Drive Next Phase of Operational Excellence

4th August 2026

Piramal Pharma Solutions Expands Peptide API Facility with Advanced Spray Drying Suite

4th August 2026

Enzene launches NeX™, a comprehensive suite of solutions to enable cost-efficient, high-yielding local biomanufacturing

3rd August 2026

CordenPharma Closes Acquisition of AmbioPharm, Strengthening Our Global Peptide Platform

30th July 2026

Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply

30th July 2026

Clean Cells acquires Anaquant to expand analytical capabilities in biomanufacturing quality control

29th July 2026

Johnson & Johnson Completes Acquisition of Firefly Bio, Inc. to Advance Next-Generation Oncology Innovation

29th July 2026

Octapharma to build $1.5 billion state-of-the-art critical care manufacturing facility in Rock Hill, SC

28th July 2026

Inizio Launches Connected Insights to Transform Global Medical Information

This week’s featured articles

Navigating Complexity: Industry Leaders on Bioprocessing, Manufacturing and Partnership Models

A woman’s view from the HAS Group

Breaking Barriers: Women Scientists Rising to Leadership in Pharma

Strategic Growth in Biologics Manufacturing: Insights from Lonza's Acquisition of the Vacaville Site

Grifols’ supply chain strategy offers lessons beyond saline

Partnered with top industry events and organisations